Alemtuzumab (anti-CD52; Campath-1H) is effective in fludarabine-refractory chronic lymphocytic leukemia (CLL), but is associated with infection and early onset neutropenia. To reduce toxicity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback